Nikki Dean

Educational Program Manager @PeerView
#MedicalEducation #MedEd #CME
Tweets are my own.

[AATS @AATSHQ]

SPONSORED: Join us Sunday, 5/3, at 6:15 PM CDT, for our resectable #NSCLC live, in-person symposium Drs. Stiles (@BrendonStilesMD), Spicer (@doctorjspicer), and Woodard (@GavittWoodard) during #AATS2026 https://t.co/NzvUDoQGv4 #Oncology

[Colorectal Cancer Alliance @CCAlliance]

New treatment options and updated guidelines are improving colorectal cancer outcomes. Tanios Bekaii-Saab, MD (@GIcancerdoc) offers guidance on therapeutic sequencing strategies in this #MedEd activity, in collaboration with @PeerView 👉 https://t.co/YCojo1vWyA

[Virgil Simons @vhsimons]

Next Wednesday we speak with Dr. Elisabeth Heath about the future of prostate cancer care.
Tune in from 4:00 to 5:00PM CET (10:00AM EST) at:
Barcelona Radio: 102.5FM - La Marina Cat
Internet: https://t.co/T3ae5R6nF6
YouTube: https://t.co/7UEW61suiO

[HopeForStomachCancer @StoCANcer]

When treatment decisions are grounded in real evidence, and the patient experience, outcomes improve. We're proud to partner with @PeerView at #ASCO26 for a live symposium on advancing gastric & GEJ cancer care on May 30th. Graphic for details.

Register: https://t.co/F6jAArEODO

[Head and Neck Cancer Alliance @hncalliance]

Reminder to join our partners @PeerView next week at #ASCO26 on 5/29 at 7:00 PM CDT for a live #HNSCC symposium. Don’t miss insights on immunotherapy and novel approaches: https://t.co/18KKC0m2ae #MedEd

[HopeForStomachCancer @StoCANcer]

Biomarker-driven care. Immunotherapy. Real-world outcomes. These aren't just buzzwords, they're what better patient care looks like.

We're joining @PeerView at #ASCO26 to bring that conversation to life.

Hear from leading experts on 5/30 at 7 PM CDT: https://t.co/w69Qlo1WPb

[HealthTree Foundation @HealthTree]

Don’t miss this live in person + virtual event with @PeerView! The Drs. Sagar Lonial (@SagarLonialMD), Nizar Bahlis, & Krina Patel (@DrKrinaPatel) are breaking down innovative strategies for RRMM care and the evolving role of #CELMoDs during #ASCO26.
🔗 https://t.co/Fl3rSFiD8d

[FdtnForWomensCancer @GYNCancer]

How are antibody-drug conjugates reshaping gynecologic cancer care? Join @PeerView at #ASCO26 on 5/29, 7 PM CDT for a live symposium with @DrKatyMoore & faculty on the latest data and practical strategies for safe, effective use. Register: https://t.co/V9xHCnACiH #Oncology #MedEd

[HopeForStomachCancer @StoCANcer]

Gastric & GEJ cancer treatment is evolving fast and patients deserve care that reflects it. Join us and @PeerView at #ASCO26 for a live symposium on biomarker-driven care, targeted therapies, and immunotherapy. 5/30 at 7 PM CDT in Chicago or virtually. https://t.co/w69Qlo1WPb

[Head and Neck Cancer Alliance @hncalliance]

Reminder to join our partners @PeerView next week at #ASCO26 on 5/29 at 7:00 PM CDT for a live #HNSCC symposium. Don’t miss insights on immunotherapy and novel approaches: https://t.co/18KKC0m2ae #MedEd

[HealthTree Foundation @HealthTree]

Excited to partner with @PeerView to bring the MoD Squad to #ASCO26! Join Drs. @SagarLonialMD, Nizar Bahlis, & @DrKrinaPatel on 5/29 at 7 PM CDT to explore
#CELMoDs in #MultipleMyeloma.
Join us live in Chicago or virtually: https://t.co/Fl3rSFiD8d

[Jen Silverman @SpeakJen]

🔥 The future of #oncology is happening now. Will you be there?

Join @PeerView at #ASCO26 for expert-led symposia covering the latest advances across solid tumors, hematologic malignancies & more‼️

💠Learn 💠Connect 💠Apply

Reserve your spot 👉 https://t.co/4fz1ZBpqzm #CME

[PeerView @PeerView]

Dr. Sabari (@JSabari) invites you to join him alongside Drs. Leighl & Jänne at #ASCO26 for a PeerView live symposium on EGFRm #NSCLC focused on treatment sequencing, resistance management & optimizing patient care #MedEd

📅 5/30 at 7 PM CDT
📍 Chicago + Virtual
🔗 https://t.co/W9BIMWXwFJ

[PeerView @PeerView]

Dr. Goldman invites you to join him alongside Dr. Camidge (@DRCamidge) & Dr. Le (@LeXiuning) at #ASCO26 for a PeerView live symposium on MET-altered #NSCLC, focused on biomarker testing, MET-targeted therapies & personalized treatment strategies: https://t.co/hjMuooDcVD #MedEd

[PeerView @PeerView]

How are emerging therapies changing #HNSCC care? Join Prof. Harrington and Drs. Burtness and Bhatia (@AartiBhatiaMD) at #ASCO26 for a PeerView Live symposium on immunotherapy, bispecific antibodies, and evolving treatment strategies in HNSCC: https://t.co/IeNOhggtxx #MedEd @YaleCancer

[PeerView @PeerView]

Dr. Morgans (@CapSurvivorship) invites you to join her and Drs. Armstrong (@AarmstrongDuke) and Heath during their session, Continuing the Innovation Story in #ProstateCancer, happening during #ASCO26 on 5/29—in Chicago and virtually: https://t.co/BBPXIdAKg0

In partnership with Prostate Net (@vhsimons) #MedEd

[Yale Cancer Center @YaleCancer]

Join Barbara Burtness, MD, and @AartiBhatiaMD at #ASCO26 for a @PeerView live symposium on advances in #HNSCC, including immunotherapy and emerging treatments in LA and R/M disease.
Join in-person in Chicago or virtually on May 29 at 7pm CDT/8pm EDT: https://t.co/xkl9fUAAuV
@SmilowCancer

[Jen Silverman @SpeakJen]

🚨 Stay ahead in oncology at #ASCO26 with @PeerView.

Join expert-led symposia in Chicago covering the latest in #NSCLC, #Melanoma, #HNSCC, #GIcancers, #GUcancers, hematologic malignancies & more.

We’ll be there—will you❓
Register 👉 https://t.co/4fz1ZBpqzm #CME

[Andrew Armstrong @AarmstrongDuke]

How are emerging therapies and biomarkers reshaping #ProstateCancer care? Join me, Drs. Heath and Morgans (@CapSurvivorship) for a @PeerView symposium during #ASCO26 on 5/29 at 7 PM CDT in Chicago or virtually. Learn more and register: https://t.co/NvsFNOBUmP

[Jen Silverman @SpeakJen]

#NSCLC care is getting more complex—and more promising 🚀

Drs. Leighl, Jänne, and @JSabari break down how to match patients to the right novel therapies.

Join @PeerView + @LUNGevity at #ASCO26
📍 Chicago | 🗓 5/30 | 6:30 PM CDT
🔗 https://t.co/oTvchSpAxu